scholarly journals Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment

2020 ◽  
Vol 49 (1) ◽  
pp. 94-110
Author(s):  
Simon G. Wong ◽  
Diane Ramsden ◽  
Shannon Dallas ◽  
Conrad Fung ◽  
Heidi J. Einolf ◽  
...  
2019 ◽  
Vol 34 (1) ◽  
pp. S44
Author(s):  
Donald Tweedie ◽  
Jane R. Kenny ◽  
Diane Ramsden ◽  
David Buckley ◽  
Shannon Dallas ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Qun Zhang ◽  
Zengqiang Qu ◽  
Yanqing Zhou ◽  
Jin Zhou ◽  
Junwei Yang ◽  
...  

Abstract Background Cornin is a commonly used herb in cardiology for its cardioprotective effect. The effect of herbs on the activity of cytochrome P450 enzymes (CYP450s) can induce adverse drug-drug interaction even treatment failure. Therefore, it is necessary to investigate the effect of cornin on the activity of CYP450s, which can provide more guidance for the clinical application of cornin. Methods Cornin (100 μM) was incubated with eight isoforms of CYP450s, including CYP1A2, 2A6, 3A4, 2C8, 2C9, 2C19, 2D6, and 2E1, in pooled human liver microsomes. The inhibition model and corresponding parameters were also investigated. Results Cornin exerted significant inhibitory effect on the activity of CYP3A4, 2C9, and 2E1 in a dose-dependent manner with the IC50 values of 9.20, 22.91, and 14.28 μM, respectively (p < 0.05). Cornin inhibited the activity of CYP3A4 non-competitively with the Ki value of 4.69 μM, while the inhibition of CYP2C9 and 2E1 by cornin was competitive with the Ki value of 11.31 and 6.54 μM, respectively. Additionally, the inhibition of CYP3A4 by cornin was found to be time-dependent with the KI/Kinact value of 6.40/0.055 min− 1·μM− 1. Conclusions The inhibitory effect of cornin on the activity of CYP3A4, 2C9, and 2E1 indicated the potential drug-drug interaction between cornin and drugs metabolized by these CYP450s, which needs further investigation and validation.


2011 ◽  
Vol 43 (1-2) ◽  
pp. 41-49 ◽  
Author(s):  
Robert Elsby ◽  
Lisa Fox ◽  
David Stresser ◽  
Mark Layton ◽  
Caroline Butters ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document